CLINICAL_TRIALS
trial_result
· 2012-05-31
Clinical Trial Update: Ilaris® in Urticarial Vasculitis - Investigation of Treatment Responses [Phase 2]
Summary
Phase 2 clinical trial evaluating canakinumab (Ilaris) for urticarial vasculitis has been completed, investigating treatment responses.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Charite University, Berlin, Germany | Conditions: Urticaria, Vasculitis | Phase 2 | Status: COMPLETED